NCT06229002

Brief Summary

stress. Notably, several studies reported that stress could alter impulsivity, source monitoring, and time perception. Several mechanisms are involved in the response to a stress factor, among them the hypothalamic-pituitary-adrenal (HPA) axis. The cortisol reactivity (it means the cortisol secretion after the exposure to a standardized stress factor) is a reliable tool to assess the function of HPA. Cortisol secretion is bidirectionally influenced by the prefrontal cortex (PFC), which is involved in the expression and regulation of stress as well. The asymmetry of the alpha band (AFα) is a well known electrophysiological parameter to assess the function of PFC. More precisely, AFα is arising a growing interest, as it is believed to be correlated with the cortisol reactivity. Modifying this asymmetry could influence the stress response. Transcranial Alternating Current Stimulation (tACS) consists in delivering a sinusoidal alternating current between two electrodes placed on the scalp at a predefined frequency. Previous studious reported that tACS, if delivered at the alpha frequency, increased the alpha band in the stimulated areas

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
21mo left

Started Jan 2024

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jan 2024Feb 2028

First Submitted

Initial submission to the registry

December 20, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

January 24, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 29, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

March 7, 2024

Status Verified

December 1, 2023

Enrollment Period

3 years

First QC Date

December 20, 2023

Last Update Submit

March 6, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Area under the curve (AUC) of the cortisol secretion after the stress task.

    Samples of salivary cortisol will be repeatedly (10 occurences) collected during the experiment. The collection will take place before, during and after the stress task.

    1 day

Secondary Outcomes (13)

  • Effect of α-tACS on the cortisol awakening response in stressed healthy subjects

    4 days

  • Effect of α-tACS on the molecular reactivity to stress

    1 day

  • Effect of α-tACS on the molecular reactivity to stress

    1 day

  • Effect of α-tACS on the molecular reactivity to stress

    1 day

  • Effect of α-tACS on the molecular reactivity to stress

    1 day

  • +8 more secondary outcomes

Study Arms (2)

Active tACS stimulation

EXPERIMENTAL

Transcranial alternative current stimulation (tACS) at alpha frequency Single session of tACS : 30 minutes, 2mA, frequency = 10Hz, both electrodes located on the dorsolateral prefrontal cortex (left and right)

Procedure: Transcranial alternative current stimulation (tACS) at alpha frequency

Sham stimulation

PLACEBO COMPARATOR

Single session of tACS sham stimulation : both electrodes located on the dorsolateral prefrontal cortex (left and right) ; real current delivered for the first and last 30s of the total stimulation time (ramp-in and ramp-out)

Procedure: Sham stimulation

Interventions

Single session of tACS

Active tACS stimulation

Single session of tACS sham stimulation

Sham stimulation

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Right-handed Men and Women aged between 18 and 45
  • If woman, hormonal contraception required
  • Having given their written informed consent
  • Affiliated with a social security scheme
  • French speakers and readers

You may not qualify if:

  • Contraindication to the exposure to exposure to tACS
  • Current psychiatric disorder as classified in the DSM-5
  • Regular intake of any psychotropic drug or Beta Blocker
  • Recent exposure to a traumatic event
  • Any debilitating condition making the experimental procedure not feasible
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Le Vinatier

Bron, AURA, 69678 CEDEX, France

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants and experimenters (including α-tACS operator) will not be informed about the nature (active or placebo) of the stimulation they will receive
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Double-blind, placebo-controlled, randomized parallel arms study including 40 healthy participants who will receive active and placebo α-tACS
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2023

First Posted

January 29, 2024

Study Start

January 24, 2024

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 1, 2028

Last Updated

March 7, 2024

Record last verified: 2023-12

Locations